Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 7,000 shares at $0.14 ($980) on 2016-07-18, disclosed to the SEC on 2016-07-19.
Open-market purchase of $980 LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |